1. HOME
2. Research Insight
3. Varian Medical Systems, Inc.(US) and Accuray Incorporated (US) are Leading Players in the Intensity-modulated Radiotherapy Market

The global intensity-modulated radiotherapy market is projected to reach USD 2.8 billion by 2028 from USD 2.2 million in 2023, growing at a CAGR of 5.2% during the forecast period. Sedentary lifestyles, high levels of stress, and a number of other factors are contributing to the daily rise in cancers like prostate, breast, lung, and kidney. A form of external beam radiotherapy called intensity-modulated radiotherapy is used to treat cancer non-invasively. Intensity-modulated radiotherapy is in high demand due to the rising incidence of cancer. The demand for the intensity-modulated radiotherapy market is growing as a result of more money being allocated to cancer research and development and increased public awareness of invasive procedures.

The intensity-modulated radiotherapy market is highly competitive, with several established players and new entrants vying for market share. The competition in the intensity-modulated radiotherapy market is driven by factors such as technological advancements, product innovation, pricing strategies, distribution networks, and regulatory compliance. Here are some of the key players in the Intensity-modulated radiotherapy market Varian Medical Systems, Inc. (US), Elekta (Sweden), and Accuray Incorporated (US) are some of the prominent companies in the intensity-modulated radiotherapy market.

To know about the assumptions considered for the study download the pdf brochure

Varian Medical Systems, Inc.(US) : In order to treat cancer with image-guided radiotherapy and radiosurgery, Varian Medical Systems, Inc. and Siemens Healthcare have partnered to provide cutting-edge diagnostic and therapeutic solutions and services. Varian's RapidArc treatment machine delivers an entire IMRT treatment in a single rotation around the patient. This can replace more time-consuming IMRT treatment methods that require machines to make several rotations around the patient or to make repeated stops and start to set up beam angles.

Accuray Incorporated (US): Accuray Incorporated is a radiation oncology company that develops, manufactures, and markets radiation therapy devices and services for innovative therapy. The company registers revenue through two market segments—Products and Services.  The major products offered by the company include CyberKnife, TomoTherapy systems, and Radixact systems. Its innovative solutions are designed to deliver advanced treatments, such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), and adaptive radiation therapy. Through its product segment, the company also offers treatment planning software that automates and accelerates the high-quality treatment plans and time to deliver treatment among patients undergoing radiotherapy. Accuray Incorporated has a presence in more than 50 countries across North America, the Middle East, Africa, and APAC; it operates through 6 office locations across five countries. Some of the company's key subsidiaries include Accuray Medical Equipment GmbH (Germany), Accuray Asia Ltd. (Hong Kong), and Accuray Spain S.L.U. (Spain), Accuray International SARL (Switzerland), Accuray Europe SAS (France), Accuray UK Ltd. (UK), Accuray Japan K.K., Accuray Medical Equipment (India) Private Ltd., Accuray Medical Equipment (Rus) LLC. (Russia), and Accuracy Medical Equipment (SEA) Private Limited (Singapore).

Elekta (Sweden): Elekta is a well-known and established player in the image-guided radiation therapy market, the company is a pioneer in precision radiation medicine and is involved in developing treatment solutions. The company's image-guided radiation therapy portfolio encompasses products designed for radiation therapy and other non-invasive procedures.

Elekta’s strong presence in the intensity-modulated radiotherapy market can be attributed to its extensive expertise in radiation medicine, commitment to research and development, and global distribution network. The company's comprehensive image-guided radiation therapy portfolio and dedication to providing high-quality products have established it as a significant player in the microcatheter market.

Related Reports:

Intensity-modulated Radiotherapy Market by Radiation Type (Photon,Electron Beam, Proton and Carbon-Ion Radiation) Application (Prostate, Lung, Breast), End Users ( Hospitals and Independent Radiotherapy centers), and Region - Global Forecasts to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]